The Role of Timed Awakening in Treatment of Enuresis

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6-17
SponsorChildren's Hospital Los Angeles

About this trial

The goal of this clinical trial is to evaluate the effectiveness of nightly timed awakening in the treatment of nocturnal enuresis in children aged 6-17. The main questions it aims to:

* Determine feasibility of nightly timed awakenings * Determine the role, if any, of comorbidities on resolution of enuresis * Determine incidence of daytime accidents * Obtain patient and parental satisfaction scores

Researchers will compare a control group to treatment groups to see if there is any impact on nocturnal enuresis.

Participants will be woken up by parents in the middle of the night to use the restroom. In addition, participants will receive 30 minute psychotherapy sessions using telehealth.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Our inclusion criteria are new and recently evaluated (within past 6 months) patients who are English-speaking

aged 6-17

referred to the urology clinic for enuresis (Enuresis in our study is defined as nocturnal or diurnal enuresis (more than 1 bedwetting episode/week) for greater than 3 months)

Disqualifiers

Diagnosis of enuresis with comorbid diagnosis of diabetes mellitus (type 1 and 2), diabetes insipidus, chronic kidney disease, polyuria and/or polydipsia

Structural urologic disease (evaluated via baseline imaging)

Diagnosis of neurodevelopmental delays or conditions (i.e. celebral palsy, autism spectrum disorder) that hinders inability to follow age-appropriate instructions

Not potty trained

Trial design

Design model

Parallel

Treatments tested in this trial

  • Nightly Timed Awakening

    Behavioral

    Patients in this arm will be awakened 1-hr after going to bed by their caregiver(s) to use the restroom and then returned to sleep. This awakening will occur every night.

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: ControlNo intervention 0 interventions
Group B: Nightly Timed AwakeningExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Mean number of wet nights reported in electronic survey weekly for 12-weeks

All study participants will report bed wetting via redcap electronic survey 1x/week for a 12-week period.

Time frame
Baseline to 12-weeks

Secondary outcomes

1

Mean change from baseline in the number of wet nights/week reported in electronic survey

All study participants will report bed wetting via redcap electronic survey 1x/week for a 12-week period.

Time frame
Baseline to 12-weeks
2

Percentage of patients with increased number of wet nights at 24-week follow-up as reported in electronic survey.

All study participants will report bed wetting via redcap electronic survey 24-week after completion of intervention

Time frame
24-weeks post-intervention
3

Mean number of nights reported weekly in electronic survey with timed awakening for 12-week period for intervention arm.

Intervention arm will report bed wetting via redcap electronic survey 1x/week for a 12-week period.

Time frame
Baseline to 12-weeks
4

Mean number of daytime accidents/week at baseline, end of 12-weeks and 24-weeks follow-up.

All study participants will report bed wetting via redcap electronic survey 24-week after completion of intervention

Time frame
Baseline to 24-week follow-up

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: